权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Specificity of RPSA-dependent translational control in mouse and human fetal spleen cells

小鼠和人胎儿脾细胞中 RPSA 依赖性翻译控制的特异性

基本信息

批准号：
10647605
负责人：
Maurizio Risolino
金额：
$ 16.15万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-01 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10647605
关键词：
Address Affect Alleles Animal Model Bacteria Biogenesis Biological Models Biology Birth Bone Marrow Cartilage-hair hypoplasia Cell Culture System Cell Culture Techniques Cell Line Cell Proliferation Cells Child Classification Clustered Regularly Interspaced Short Palindromic Repeats Collection Comprehension Congenital Abnormality Defect Development Developmental Process Diamond Disease Dyskeratosis Congenita Dysmyelopoietic Syndromes Embryo Encapsulated Erythropoiesis Fetal Spleen Fetus Genes Heterozygote Host Defense Human Impairment Individual Infection Knowledge Life Light Link Literature Loss of Heterozygosity Macrocytic Anemia Mandibulofacial Dysostosis Measures Mediating Mesenchymal Messenger RNA Modeling Molecular Molecular Abnormality Mouse Strains Mus Mutation Newborn Infant Organogenesis Pathogenesis Patients Phenocopy Phenotype Play Predisposition Process Protein Biosynthesis Proteins Research Ribosomal Proteins Ribosomes Role Specificity Spleen Spleen Development System Testing Tissues Translating Translations blastomere structure body system cell type clinical phenotype embryo cell erythroid differentiation exome sequencing experimental study genome editing genome-wide in utero in vivo loss of function mouse model mutant ribosome profiling ribosomopathy

项目摘要

Project Summary/Abstract Ribosomopathies comprise a collection of disorders in which genetic abnormalities cause impaired ribosome biogenesis and function. Despite the need for ribosomes in all cell types, ribosomopathies display specific clin- ical phenotypes. Human Isolated Congenital Asplenia (ICA), which manifests at birth as absence of the spleen, or as hypoplastic spleen, without additional developmental anomalies, has been recently classified as a ri- bosomopathy. Given the central role of the spleen in host defense, ICA patients are vulnerable to life- threatening blood-borne infections. Germline heterozygous mutations were identified in the gene encoding RPSA [ribosomal protein (RP) SA; a component of the ribosome small subunit] in a large proportion of ICA pa- tients. The critical role for RPSA in human spleen development was surprising, given that mutations in other RPs had never been associated with asplenia. While spleen development constitutes an ideal system to study specific functions of RPs, animal models generated so far cannot be used to determine how deficiency of RPSA affects spleen development. Indeed, homozygosity for a null Rpsa allele causes early lethality in utero, while heterozygosity is not associated with asplenia. In order to overcome these limitations and to identify RPSA spleen-specific functions, we have generated mouse embryonic spleen cells with deficiency of either Rpsa or Rps14 (of note, haploinsufficiency of RPS14 causes impaired erythropoiesis in humans, without spleen defects). Preliminary results show that cell proliferation and protein synthesis are more strikingly re- duced in Rpsa versus Rps14 mutant splenic cell lines. Yet, little is known about the mechanisms underlying the specificity of RPSA-dependent phenotypes in mouse spleen cells and the potential conservation of these mechanisms in humans. We hypothesize that RPSA plays “specialized” roles that are restricted only to spleen development in mouse and humans. We plan to test this hypothesis via these specific aims: 1. To assess specificity of RPSA haploinsufficiency in a tractable murine spleen model system. By using unbiased genome-wide approaches (Ribo-seq), we will assess translation dynamics and we will measure actively trans- lated mRNAs in wildtype and mutant (deficient for Rpsa and Rps14, respectively) mouse embryonic spleen mesenchymal cells. These experiments will define RPSA-dependent mechanisms and translational targets that render spleen embryonic cells more susceptible to loss of RPSA versus RPS14. 2. To assess whether RPSA functions are conserved in a human spleen model system. We will generate and characterize human splenic cell cultures with RPSA deficiency by performing genome editing of RPSA in splenic mesenchymal cells obtained from human fetuses. These experiments will determine whether RPSA-dependent defects in mouse embryonic spleen cells, identified in Aim1, are conserved in human fetal spleen cells. This research will be ground-breaking as it will uncover unique mechanisms underpinning specific functions of ribosomal proteins in spleen development, as well as shedding light on the pathogenesis of ICA, a life-threatening birth defect.

项目总结/文摘